Todd Shryock is managing editor of Medical Economics.
Orchestra BioMed receives Breakthrough Device Designation for its hypertension therapy
April 22nd 2025The company received the designation for its atrioventricular interval modulation therapy, a novel pacemaker-based treatment aimed at reducing blood pressure in patients with uncontrolled hypertension and elevated cardiovascular risk.